The copy number ranges for these genes varied widely, with NSD3/WHSC1L1 amplified at high copy number levels (5–15 copies) in breast cancer patients, while SETDB1 was amplified at 3–6 copy range in melanoma (Figure 7A). This evidence concerns the gene NSD3 and breast carcinoma.